NCT00088608View on ClinicalTrials.gov

A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2006

Conditions
Cushing's Syndrome
Interventions
DRUG

SOM230 s.c.

Trial Locations (5)

19104

University of Pennsylvania, Philadelphia

53215

Midwest Endocrinology Associates, Milwaukee

90048

Cedars-Sinai Pituitary Center, Los Angeles

97239

Oregon Health & Science University, Portland

02114

Massachusetts General Hospital NE Unit, Boston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY